Share This Video

Glucagon: A Major Player in Type 2 Diabetes

In this video, Dr. Charles Reasner provides insight into the important role of glucagon in glucose homeostasis and type 2 diabetes.
Charles Reasner, MD
Adjunct Professor of Medicine University of Texas Health Science Center
San Antonio, Texas
Charles Reasner, MD

References:

  1. DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773-795.
  2. Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;27(2):136-142.
  3. Baron AD, Schaeffer L, Shragg P, Kolterman OG. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes. 1987;36(3):274-283.
  4. Henquin JC, Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia. 2011;54(7):1720-1725.
  5. Drucker DJ. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol. 2003;17(2):161-171.
  6. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeld W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36(8):741-744.
  7. Bagger JI, Knop FK, Lund A, Holst JJ, Vilsbøll T. Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals. Diabetologia. 2014;57(8):1720-1725.
  8. Müller WA, Faloona GR, Aguilar-Parada E, Unger GH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970;283(3):109-115.